Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs U.S. Asthma Therapeutics Market
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

U.S. Asthma Therapeutics Market

DateApr, 2001
Pages0
Price / format€3948 / Hard Copy
€3571 / Site License
€4701 / Enterprisewide

€3 542 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:

New Product Classes Offer Significant Growth Opportunities

The emergence of leukotriene modifiers and combination therapies show
promise in a highly competitive market. Leukotriene modifiers are

maintenance therapy drugs and an alternative to the long-term use of
corticosteroids. Convenience is the primary advantage of combination
therapies, as these pills combine two or more asthma drugs into one dosage,
making treatment more efficient. Both product classes result in increased

compliance as patients realize the benefits of these orally-administered and
easy-to-use therapies.

This Frost &Sullivan study forecasts future revenues of the drug classes that
dominate the prescription asthma drug market: brochodilators, anti-inflammatories, leukotriene modifiers, and combined therapies, while also offering an
overview of new drug classes in development. This deliverable provides
market drivers and restraints for each drug segment, and recommends
strategies to formulate an efficient business plan.

Developing Brand Loyalty Essential for Success

It is important that drug manufacturers market their asthma therapies to all

healthcare groups that diagnose and treat asthma in an effort to build brand
loyalty. Asthma is treated by a number of different medical professionals,
including primary care physicians, respiratory specialists, and emergency room
doctors, all of whom use diverse treatments for this disease.

The primary care physician segment presents the largest opportunity to build
a successful and loyal following. Primary care providers account for nearly 56
percent of all prescriptions written for asthma medications, states the author
of this study. Implementing educational campaigns to promote brand loyalty
among all provider groups is a key opportunity to increase market share.

Market for Mild Asthmatics Poised for Expansion

An estimated 90 percent of patients suffering from severe persistent asthma
get treated with prescription drugs, while only five to eight percent of mild
intermittent cases receive prescriptions, states the author..
The mild intermittent patient group has a huge revenue potential, as it
represents the largest patient segment. Companies that can increase their
penetration rates among this group through new, innovative therapies, and
targeted marketing campaigns, see greater returns on their investments.

This Frost &Sullivan research provides the most current intelligence available
on the U.S. asthma therapeutics market. By identifying the latest drivers and
restraints this report enables you to fully evaluate this market 's potential and
design strategies for future success.

Additional Information

Market Participants
Alpharma,Inc./U.S.Pharmaceutical Division

AstraZeneca

AstraZeneca LP
Aventis Pharmaceuticals,Inc.
Bausch &Lomb Pharmaceuticals,Inc.

Boehringer Ingelheim
Copley Pharmaceuticals,Inc.
Dey,Inc.
Dura Pharmaceuticals,Inc.

GlaxoSmithKline

Medeva Pharmaceuticals

Novartis Pharmaceuticals Corporation

Pfizer

Purdue Pharma LP
Sanofi-Synthelabo,Inc.

Schering-Plough HealthCare Products

Teva Pharmaceutials USA

Related Companies

3M Pharmaceuticals

Alliance Pharmaceuticals Corporation
Berlex Laboratories,Inc.

Inhale Therapeutic Systems

McKesson HBOC
Merck-Medco Managed Care,LLC

Associations

American Association for Respiratory Care

American Lung Association

California Society for Respiratory Care
National Heart,Lung,and Blood Institute

National Jewish Medical Research Center

Trade Organizations

National Pharmaceutical Council










Table of contents:
 1. Executive Summary
A. Introduction to the Prescription Asthma Drugs Market
1.Objectives and Purpose
2.Report Scope and Segmentation
3.Report Structure
B. Summary of Major Findings
1.Total Revenue Forecasts
2.Percent of Revenues by Product Type
3.Analysis by Major Segment
a. Bronchodilator Asthma Drugs Market
i. Major Drivers for the Bronchodilator Asthma Drugs Market
ii. Major Restraints for the Bronchodilator Asthma Drugs Market
b. Inhaled Anti-Inflammatory Asthma Drugs Market
i. Major Drivers for the Inhaled Anti-Inflammatory Asthma Drugs Market
ii. Major Restraints for the Inhaled Anti-Inflammatory Asthma Drugs Market
c. Leukotriene Modifiers and Emerging Asthma Drugs Market
i. Major Drivers for the Leukotriene Modifiers Asthma Drugs Market
ii. Major Restraints for the Leukotriene Modifiers Asthma Drugs Market
4.Competitive Analysis
a. Competitive Structure
b. Major Players
c. Market Entrants

2.Market Engineering Research Methodology
A. Research Scope
1.Objectives and Purpose
2.Report Structure and Market Segmentation
B. Research Methodology
1.Frost &Sullivan's 12 Step Methodology
2.Step 1:Define Market Problems, Needs, and Opportunities
a. Phase One:Analysis
b. Phase Two: Kickoff Meeting
3.Step 2:Define Objectives and Goals of the Research Project
4.Step 3:Design Optimal Research Team
a. Lead Research Analyst
b. Support Research Analyst
c. Research Directors
d. Account Executives
e. Market Engineering Consultants
f. Key Customers
g. Industry Advisers
5.Step 4:Launch Data Collection Phase
6.Step 5:Select Interview Strategy and

Design of Survey
7.Step 6:Test the Survey Design
8.Step 7:Conduct Primary Market Research
a. Cross-Verification of Data
b. Bottom-Up Approach
c. Bottom-Up Versus Top-Down Approach
d. Measuring Revenue Growth Rate
9.Step 8:Research Analysis: Finding Point A
10.Step 9:Market Forecasting: Finding Point B
a. Expert-Opinion Consensus Model
11.Step 10:Develop Strategic Recommendations
a. Who Is Winning, Who Is Losing, and Why?
12.Step 11:Confirm Results with Quality Control
a. Research Director's Final Review
b. Final Client Preparation
13.Step 12:Market Monitoring and Customer Feedback Review
a. Market Monitoring
b. Customer Feedback and Review
c. Continuous Market Research Monitoring
C. Market Engineering Forecasting Methodology
1.Overview
a .Market Engineering Research Process Completed
b. Measurements and Challenges Analyzed Over Time
c. Identification of Market Drivers and Restraints
d. Expert-Opinion Integration with Analyst Team
E .Forecasts Calculated
f. Delphi Technique Integration When Needed
G .Quality Control Within Research Department
2.Strategic Significance of the Market Engineering Forecast
3.Judging Credibility and Accuracy of Market Engineering Forecasts
4.Forecast Assumptions

3.Identification of Challenges Facing the Pharmaceutical Industry

4.Overview of Asthma
A. Definition
B. Etiology and Pathophysiology of Asthma
1.Disease Overview
2.Inflammation in Asthma
3.Asthma Types
4.Disease Incidence and Patient Population

5.Market Engineering Research for the U.S. Bronchodilator Asthma Drugs Market 1996 -2006
A. Market Overview and Definitions
1.Overview
2.Definition
3.Scope/Segmentation
4.History
5.Applications/Use
B. Market Engineering Research Measurement System
C. Market Drivers
D. Market Restraints
E. Market Engineering Revenue Forecasts (1996 -2006)
1.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
2.Pricing Analysis
a. Methodology
b. Major Pricing Trends
3.Revenues
F. Technology Trends
G. Competitive Analysis
1.Competitive Structure
2.Competitive Factors
3.Mergers,Alliances, and Acquisitions
4.Market Share Analysis
a. Schering-Plough
b. Glaxo Wellcome
c. Boehringer Ingelheim
H. Product Analysis
1.Products on the Market
a. Proventil and Ventolin (Albuterol)
b. Serevent (Salmeterol)
c. Atrovent (Ipratropium Bromide)
d. Other Drugs
2.Products in Clinical Trials

6.Market Engineering Research for the U.S. Inhaled Anti-Inflammatory Asthma Drugs Market 1996 -2006
A. Market Overview and Definitions
1.Overview
2.Definition
a. Corticosteroids
b. Mast-Cell Stabilizers
3.Scope/Segmentation
4.History
5.Applications/Use
B. Market Engineering Research Measurement System
C. Market Drivers
D. Market Restraints
E. Market Engineering Revenue Forecasts (1996 -2006)
1.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
2.Pricing Analysis
a. Methodology
b. Major Pricing Trends
3.Revenues
F. Technology Trends
G. Competitive Analysis
1.Competitive Structure
2.Competitive Factors
3.Market Share Analysis
H. Product Analysis
1.Products on the Market
a. Vanceril and Beclovent (Beclomethasone)
b. Flovent (Fluticasone)
c. Pulmicort (Budesonide)
d. Aerobid (Flunisolide)
e. Azmacort (Triamcinolone)
f. Intal (Cromolyn Sodium)and Tilade (Nedocromil Sodium)
2.Products in Clinical Trials

7.Market Engineering Research for the U.S. Leukotriene Modifiers and Emerging Asthma Therapies Market

1996 -2006
A. Leukotriene Modifiers Asthma Drugs Market
1.Market Overview and Definitions
a. Overview
b. Definition
c. Scope/Segmentation
d. Possible Applications/Use
2.Market Engineering Research Measurement System
3.Market Drivers
4.Market Restraints
5.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
6.Pricing Analysis
a. Methodology
b. Major Pricing Trends
7.Revenues
8.Competitive Analysis
a. Competitive Structure
b. Competitive Factors
c. Market Share Analysis
9.Product Analysis
a. Products on the Market
i. Accolate (Zafirlukast)
ii. Zyflo (Zileuton)
iii. Singulair (Montelukast)
b. Leukotriene Modifiers in Clinical Trials
B. Combination Asthma Drug Therapies and Emerging Trends
1.Market Overview and Definitions
a. Overview
b. Definition
c. Scope/Segmentation
2.Market Drivers
3.Market Restraints
4.Market Engineering Revenue Forecasts (2000 -2006)
a .Patient Population (Demand Analysis)
i. Methodology
ii. Major Trends
b. Pricing Analysis
i. Methodology
ii. Major Pricing Trends
c. Revenues
5.Combination Therapies in Clinical Trials
6.Other Trends in Asthma Therapy
a. Personalizing Medications
b. Asthma Physiolab by Entelos
c. Other Products in Clinical Trials

8.Market Engineering Strategy
A. What Is Market Engineering Strategy?
1.Measurement-Driven Strategy Generation
a. Market Engineering Challenges Versus Departmental Responsibility
b. Market Engineering Measurement Trends Versus Departmental Responsibility
B. Market Engineering Strategic Recommendations
1.Corporate Management
2.Marketing
3.Research and Development

9.Market Engineering Planning
A. Integrating Market Engineering into the Business Planning Process
1.Current Company Status Location
2.Desired Status
3.Developing the Strategy
4.Implementing the Strategy

10.Implementation of Market Engineering
A. How to Implement Market Engineering in a Company

11.Market Engineering Monitoring of the Asthma Drugs Market
A. Purpose of Market Engineering Monitoring

12.Market Engineering Awards for the Prescription Asthma Drugs Market
A. Frost &Sullivan's 2001 Market Engineering Awards
B. Market Engineering Awards
1.Award Category: Marketing Strategy Leadership
a. Award Description
b. Research Methodology
c. Measurement Criteria
d. Award Recipient
2.Award Category: Product Innovation
a. Award Description
b. Research Methodology
c. Measurement Criteria
d. Award Recipient
3.Award Category: Product Line Strategy
a. Award Description
b. Research Methodology
c. Measurement Criteria
d. Award Recipient




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com